Aquablation of the prostate

Aquablation of the prostate is a robot-assisted therapy procedure for patients with benign prostate enlargement. Prostate tissue is ablated using a high-pressure water jet.

The system consists of an ultrasound probe, a computer console and a robotic handpiece.

The handpiece is inserted into the urethra under cystoscopic control and fixed to a holding arm. The tissue to be removed is marked in real time using a transrectal ultrasound. By planning the ablation area in a longitudinal and axial direction, the surgeon can determine exactly how much tissue is to be removed and at which positions. A probe is used to generate a high-pressure jet of saline solution orthogonal to the tissue, which ablates the prostate tissue. The depth of penetration can be regulated via the flow rate. The surgical procedure is performed under constant medical supervision. Aquablation is a procedure that does not use heat energy.

The removed tissue is evacuated with a bubble syringe. If necessary, the tissue is then resected/coagulated with a conventional TUR snare to stop the bleeding.

Previous studies have assessed the effectiveness of aquablation as similar to that of TUR prostate. The procedure has so far been investigated for prostate volumes between 30 cc - 150 cc.

Aquablation therapy of the prostate is currently only used in patients who do not need to take "blood thinners" (e.g. Marcumar, Clopidogrel, Xarelto or similar). Taking ASA 100 is not a contraindication to the therapy.

If you are interested in this therapy procedure, you are welcome to make an appointment for a consultation in our Clinical Department.

Reporting "MHH Insight", 14.03.2022